Molecule intelOpportunity: ModerateEssential

Diloxanide

65 brands · 54 companies · product forms

ATC: P01AC01

Opportunity snapshot

Launch attractiveness
38
Market saturation
83
Price room
100
Regulatory risk
0
65
brands
54
companies
Rs 140.66
median price
25
price points
6.03x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 62.93
MedianRs 140.66
Most expensiveRs 379.53
Spread6.03×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 6.03x across 25 trusted points (Rs 62.93-379.53). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 8 live products for Diloxanide — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(17) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

54 canonical companies and 65 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 6.03x across 25 trusted points (Rs 62.93-379.53). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.